CERKL and neoplasm: In addition, we identified a tumour-specific ~7.5 Mb CNV on chromosome 2 harbouring genes as ITGA4, CERKL, PPP1R1C and PDE1A (Additional file 16: Figure S9b), underscoring the potential of our platform for identifying structural abnormalities.